MED12 and acute myeloid leukemia: In contrast [25], patients with atypical CK AML, who are generally younger, frequently have mutations in PHF6, FLT3-TKD, MED12, and NPM1, and tend to achieve a longer overall survival compared to those with typical CK AML [24].